51,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

The burden of malignant growth is huge and continuously increasing in low-and middle-income countries (LMICS). Paradoxically, proportionate expansion of assets to control diseases either from household spending plans or universal guide in LMICS, is lacking. Most populaces in LMICS urgently need proper access to powerful disease counteractive actions, treatments and concealment. This volume, CANCER: THE TREMOR, the pioneer part of the first version gives a modern review of the historical backdrop of malignant growth, reasons for the disease, incidence of tumors, pathological viewpoint,…mehr

Produktbeschreibung
The burden of malignant growth is huge and continuously increasing in low-and middle-income countries (LMICS). Paradoxically, proportionate expansion of assets to control diseases either from household spending plans or universal guide in LMICS, is lacking. Most populaces in LMICS urgently need proper access to powerful disease counteractive actions, treatments and concealment. This volume, CANCER: THE TREMOR, the pioneer part of the first version gives a modern review of the historical backdrop of malignant growth, reasons for the disease, incidence of tumors, pathological viewpoint, prognosis, apoptosis, viability and possibility of intercessions for the diseases that force high sickness troubles in LMICS. The aim of this book is to provide a detail diagram of the standards of malignancy care to the Health Professionals, Pharmaceutical/Medicinal understudies at their dimension proficiently instead of at learner's level.
Autorenporträt
Dr. Faruk Alam is working as an Associate Professor in Assam Down Town University, Assam. He has authored three books, published more than 35 research and review articles in national/International journals of repute, presented several scientific papers and delivered invited lectures in various national/international conferences.